
New Study Says Lab Test Can Reliably Identify Bleeding Risk in Xarelto Patients
Plaintiff attorneys say three recently decided Xarelto bellwether trials may have ended differently if jurors would have access
Learn MorePlaintiff attorneys say three recently decided Xarelto bellwether trials may have ended differently if jurors would have access
Learn MoreThe U.S. Food and Drug Administration is currently reviewing a new low-dose version of the blood thinner Xarelto
Learn MoreAccording to the Institute for Safe Medication Practices (ISMP), the U.S. Food and Drug Administration (FDA) received 15,043
Learn MoreAccording to a cohort study published recently in JAMA Internal Medicine, patients using Xarelto (rivaroxaban) are more likely
Learn MoreAlthough Johnson & Johnson and Bayer AG won the first battle when a jury found that the companies
Learn More